Unknown

Dataset Information

0

Effect of Cannabis Use on Human Immunodeficiency Virus DNA During Suppressive Antiretroviral Therapy.

ABSTRACT: Cannabis use is frequent among people living with human immunodeficiency virus (HIV) and is associated with reduced systemic inflammation. We observed a faster HIV DNA decay during antiretroviral therapy among cannabis users, compared to those with no drug use. No cannabis effect was observed on cellular HIV RNA transcription.

SUBMITTER: Chaillon A 

PROVIDER: S-EPMC6912153 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Effect of Cannabis Use on Human Immunodeficiency Virus DNA During Suppressive Antiretroviral Therapy.

Chaillon Antoine A   Nakazawa Masato M   Anderson Christy C   Christensen-Quick Aaron A   Ellis Ronald J RJ   Franklin Donald D   Morris Sheldon R SR   Gianella Sara S  

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20200101 1

Cannabis use is frequent among people living with human immunodeficiency virus (HIV) and is associated with reduced systemic inflammation. We observed a faster HIV DNA decay during antiretroviral therapy among cannabis users, compared to those with no drug use. No cannabis effect was observed on cellular HIV RNA transcription. ...[more]

Similar Datasets

Unknown Blood and Lymph Node Dissemination of Clonal Genome-Intact Human Immunodeficiency Virus 1 DNA Sequences During Suppressive Antiretroviral Therapy.
| S-EPMC8493664 | biostudies-literature
Unknown Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral Therapy.
| S-EPMC7850524 | biostudies-literature
Unknown Longitudinal variation in human immunodeficiency virus long terminal repeat methylation in individuals on suppressive antiretroviral therapy.
| S-EPMC6743183 | biostudies-literature
Unknown Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Individuals.
| S-EPMC6248381 | biostudies-literature
Unknown Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy.
| S-EPMC6688057 | biostudies-literature
Unknown Impact of fluctuation in frequency of human immunodeficiency virus/simian immunodeficiency virus reactivation during antiretroviral therapy interruption.
| S-EPMC7482276 | biostudies-literature
Unknown Emergence of resistance mutations in simian immunodeficiency virus (SIV)-infected rhesus macaques receiving non-suppressive antiretroviral therapy (ART).
| S-EPMC5821307 | biostudies-literature
Unknown Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy.
| S-EPMC5407052 | biostudies-literature
Unknown HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy.
| S-EPMC4200019 | biostudies-literature
Unknown Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy.
| S-EPMC4547398 | biostudies-literature